Managers / Q1 2026 · view latest →
Crescent Sterling, Ltd.
CIK 0001962005 · 4415 SHORES DRIVE, SUITE 250, METAIRIE, LA, 70006 · 5048851135
Summary
Crescent Sterling, Ltd. reported $103M in U.S.-listed holdings across 80 positions for Q1 2026.
Its largest position, Schwab Strategic Tr, represents 8.0% of the portfolio.
Compared with Q4 2025, the fund opened 5 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 73.1% · $76M
- ETP · 24.6% · $25M
- ADR · 1.3% · $1M
- Other · 0.8% · $826,233
- REIT · 0.3% · $331,229
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MPCMARATHON PETE CORP | NEW | +1.0K | 1.0K | +$250,522 | $250,522 |
| BABOEING CO | NEW | +1.2K | 1.2K | +$247,593 | $247,593 |
| OKEONEOK INC NEW | NEW | +2.5K | 2.5K | +$224,890 | $224,890 |
| ARMARM HOLDINGS PLC | NEW | +1.4K | 1.4K | +$219,053 | $219,053 |
| ISHARES TR | NEW | +324 | 324 | +$211,880 | $211,880 |
| VANGUARD SCOTTSDALE FDS | ADDED | +7.5K | 14.1K | +$593,641 | $1M |
| PCARPACCAR INC | SOLD OUT | −7.0K | 0 | −$765,643 | $0 |
| REGNREGENERON PHARMACEUTICALS | SOLD OUT | −279 | 0 | −$215,352 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2026 | $112M | 85 | Jul 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q1 2026 | $103M | 80 | Apr 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $98M | 78 | Jan 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $95M | 74 | Oct 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $89M | 72 | Aug 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $98M | 75 | Apr 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $97M | 75 | Jan 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $105M | 77 | Oct 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $104M | 77 | Jul 17, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $110M | 80 | Apr 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $100M | 76 | Jan 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $95M | 72 | Oct 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $105M | 78 | Aug 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $103M | 74 | Apr 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $93M | 66 | Jan 20, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.